PTM BIO LLC, founded in 2011 and headquartered in Chicago, IL, operates at the forefront of the Biotechnology and Health Care industries. This innovative company addresses significant unmet needs in life sciences and personalized medicine by creating advanced technologies specifically tailored for biological reagents, proteomics, and diagnostics.
Having established itself as a world leader in high throughput proteomics technology and premium epigenetics reagents, PTM BIO LLC has become instrumental in accelerating research in protein post-translational modification and epigenetics. The company's commitment to an innovation-driven philosophy and a customer-first business model positions it strategically for growth across the value chain.
Despite its achievements, details regarding its last investment and investors remain undisclosed. As PTM BIO LLC continues to optimize growth opportunities, it presents a compelling opportunity for potential investors seeking to engage with a leader in biotechnology advancements.